bosentan anhydrous has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bir, F; Enli, Y; Ergin, H; Özdemir, ÖM; Şahin, B; Taban, Ö | 1 |
| Bargalló, R; Bulbena, O; Gelpí, E; Peralta, C; Prats, N; Roselló-Catafau, J | 1 |
2 other study(ies) available for bosentan anhydrous and Chronic Lung Injury
| Article | Year |
|---|---|
The effects of bosentan on hyperoxia-induced lung injury in neonatal rats.
Topics: Actins; Animals; Animals, Newborn; Biomarkers; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperoxia; Immunohistochemistry; Injections, Intraperitoneal; Lung; Lung Injury; Rats; Rats, Wistar; Treatment Outcome | 2019 |
Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion.
Topics: Animals; Bosentan; Endothelin-1; Liver; Liver Transplantation; Lung Injury; Male; Microscopy, Electron; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides; Transplantation Conditioning; Tumor Necrosis Factor-alpha | 2000 |